Financial results - EASTERN BIOLOGIX SRL

Financial Summary - Eastern Biologix Srl
Unique identification code: 36682340
Registration number: J2016014172402
Nace: 8690
Sales - Ron
1.885.466
Net Profit - Ron
458.729
Employees
14
Open Account
Company Eastern Biologix Srl with Fiscal Code 36682340 recorded a turnover of 2024 of 1.885.466, with a net profit of 458.729 and having an average number of employees of 14. The company operates in the field of Alte activitati referitoare la sanatatea umana having the NACE code 8690.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Eastern Biologix Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - 0 88.060 962.320 1.234.172 328.112 622.018 1.049.071 1.248.155 1.885.466
Total Income - EUR - 0 93.723 986.310 1.251.836 339.266 649.987 1.050.336 1.248.653 1.914.137
Total Expenses - EUR - 131 105.149 700.900 1.064.137 615.092 645.952 875.860 1.048.828 1.379.448
Gross Profit/Loss - EUR - -131 -11.426 285.409 187.699 -275.826 4.036 174.477 199.825 534.689
Net Profit/Loss - EUR - -131 -15.027 277.711 168.891 -275.826 4.036 167.195 191.932 458.729
Employees - 0 6 19 22 0 17 10 12 14
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 51.9%, from 1.248.155 euro in the year 2023, to 1.885.466 euro in 2024. The Net Profit increased by 267.869 euro, from 191.932 euro in 2023, to 458.729 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Eastern Biologix Srl

Rating financiar

Financial Rating -
EASTERN BIOLOGIX SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Eastern Biologix Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Eastern Biologix Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Eastern Biologix Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Eastern Biologix Srl - CUI 36682340

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - 1.441 26.491 38.830 32.583 25.122 18.662 15.543 336.440 348.461
Current Assets - 7.115 64.183 282.867 215.203 48.532 91.179 482.770 212.586 627.801
Inventories - 0 0 0 0 0 0 0 0 0
Receivables - 6.572 43.274 138.653 135.667 45.182 66.488 469.578 196.991 585.212
Cash - 544 20.908 144.214 79.536 3.350 24.690 13.192 15.595 42.589
Shareholders Funds - 2.096 -12.966 264.983 171.419 -452.397 -438.329 15.487 207.372 626.952
Social Capital - 2.227 2.189 2.149 2.107 2.067 2.022 2.028 2.022 2.010
Debts - 6.460 104.197 56.714 97.125 526.052 548.169 482.826 340.456 348.514
Income in Advance - 0 0 0 0 0 0 0 1.199 795
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8690 - 8690"
CAEN Financial Year 8690
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 627.801 euro in 2024 which includes Inventories of 0 euro, Receivables of 585.212 euro and cash availability of 42.589 euro.
The company's Equity was valued at 626.952 euro, while total Liabilities amounted to 348.514 euro. Equity increased by 420.739 euro, from 207.372 euro in 2023, to 626.952 in 2024. The Debt Ratio was 35.7% in the year 2024.

Risk Reports Prices

Reviews - Eastern Biologix Srl

Comments - Eastern Biologix Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.